InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Promising Preclinical Results for SPC-15 in Treating Severe Psychiatric Disorders

Stock Information for Silo Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.